Search

  • Sort by

  • Category

  • Post Type

  • Reset

Maryland-UPL-review-process-11-24

November 20, 2024
Read More

November 18, 2024: Regulators struggle with GLP-1s in the U.S. and abroad

November 18, 2024
Posted in

Novo Nordisk filed five more lawsuits against businesses selling compounded semaglutide. Dr. Tim Mackey spoke about the dangers of the unregulated semaglutide sales online, and South Africa warned residents about counterfeit Ozempic.

Read More

UK-Oct-2019-etizolam-bust

November 18, 2024

“Humberside Police raided an industrial unit in Winterton Road, Scunthorpe, in October 2019 and discovered machinery and raw materials to produce thousands of etizolam tablets – a type of tranquilliser and a Class C drug in the UK.”

Read More

GLP-1-lawsuits-11-2024

November 18, 2024
Read More

FDA Alert: Dietary Supplement Recalled Due to Presence of Sildenafil and Diclofenac

November 14, 2024
Posted in ,

Consumption of products with undeclared sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Among the adult male population, who are most likely to use this product, adult males who use nitrates for cardiac conditions are most at risk.

Read More

VitalityVita back

November 14, 2024
Read More

VitalityVita

November 14, 2024
Read More

ZoomMax back

November 14, 2024
Read More

ZoomMax front

November 14, 2024
Read More

FDA Alert: Dietary Supplement Contains Drug That Can Cause Heart Attack, Stroke and Internal Bleeding

November 14, 2024
Posted in ,

Use of products with undeclared diclofenac may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products.

Read More